Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Fall Late Afternoon

Sector Update: Healthcare Stocks Fall Late Afternoon

MT newswireMT newswire2026/09/30 20:00
04:00 PM EDT, 09/30/2026 (MT Newswires) -- Healthcare stocks declined late Wednesday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.1%. The iShares Biotechnology ETF (IBB) rose 0.1%. In corporate news, a federal judge in Minnesota granted in part and denied in part UnitedHealth's (UNH) motion to dismiss a suit brought by the California Public Employees' Retirement System that accuses the company of violating the Securities Exchange Act and a Securities and Exchange Commission rule, a court filing showed. UnitedHealth shares fell 1.8%. Liquidia (LQDA) shares plunged 57%. A federal court in Delaware ruled that the company infringed two claims of a United Therapeutics (UTHR) patent covering the use of inhaled treprostinil to treat pulmonary hypertension associated with interstitial lung disease, including dry-powder formulations. United Therapeutics shares jumped 12%. Eli Lilly (LLY) reported positive results from a phase 2b trial of its investigational combination of eloralintide and tirzepatide in 367 obese or overweight adults with type 2 diabetes. Lilly shares fell 1.5%. Moderna (MRNA) appointed Juan Andres to the newly created role of chief operating officer, effective Monday. Separately, Citigroup downgraded Moderna stock to sell from neutral, The shares fell 5.4%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21